These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 722960)

  • 41. Choleretic properties of ursodeoxycholic acid and chenodeoxycholic acid in dogs.
    Yanaura S; Ishikawa S
    Jpn J Pharmacol; 1978 Jun; 28(3):383-9. PubMed ID: 702942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Routine determination of biliary lipid composition with the entero-test.
    Muraca M; Pazzi P; Vilei MT; Miconi L; Granato A; Cianci V; Sighinolfi D; Alvisi A; Gerunda G; Maffei Faccioli A
    Ann Chir; 1994; 48(2):197-200. PubMed ID: 8192414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation.
    Logan GM; Duane WC
    Gastroenterology; 1990 Jun; 98(6):1572-6. PubMed ID: 2338194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones.
    Lanzini A; Northfield TC
    Gastroenterology; 1988 Aug; 95(2):408-16. PubMed ID: 3391368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I.
    Bachrach WH; Hofmann AF
    Dig Dis Sci; 1982 Aug; 27(8):737-61. PubMed ID: 7094795
    [No Abstract]   [Full Text] [Related]  

  • 46. Utility of biliary microscopy for the prediction of the chemical composition of gallstones and the outcome of dissolution therapy with ursodeoxycholic acid.
    Ros E; Navarro S; Fernández I; Reixach M; Ribó JM; Rodés J
    Gastroenterology; 1986 Sep; 91(3):703-12. PubMed ID: 3732768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative study of the effects of an average dose of chenodesoxycholic acid and a high dose of ursodesoxycholic acid (dosage equivalents: 15 mg/kg/day) on the composition of lipids and bile acids in the bile of patients with radiotransparent biliary lithiasis].
    Garrido G; Bretó M; Pérez F; Berenguer J
    Rev Clin Esp; 1983 Jul 15-31; 170(1-2):31-6. PubMed ID: 6635274
    [No Abstract]   [Full Text] [Related]  

  • 48. Stratification of bile in gallbladder and gallstone formation.
    Nakayama F; van der Linden W
    Surg Gynecol Obstet; 1975 Oct; 141(4):587-90. PubMed ID: 1166388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile acid composition.
    Batta AK; Salen G; Shefer S; Tint GS; Dayal B
    Hepatology; 1982; 2(6):811-6. PubMed ID: 7141393
    [No Abstract]   [Full Text] [Related]  

  • 50. [Physicochemical analysis of bile in normal subjects and in patients with cholesterol gallstones (author's transl)].
    Palma R; Antezana C; Wunkhaus R; Csendes A
    Rev Med Chil; 1975 Sep; 103(9):594-97. PubMed ID: 1209044
    [No Abstract]   [Full Text] [Related]  

  • 51. [Symposium on pathophysiology of biliary tract diseases with special emphasis on gallstone disease. Supplementary (2) Serum lipids and the pattern of lipoproteins in cholelithiasis and their relation to the compositional change of bile and bile acids (author's transl)].
    Yamamoto A; Kaki-Uchi Y
    Nihon Naika Gakkai Zasshi; 1977 Sep; 66(9):1209-11. PubMed ID: 591761
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
    Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S
    Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New therapeutic methods--technics, application, efficacy and problems. Litholysis. a) Theory of litholysis and development of litholytic agents].
    Makino I; Yoneda M; Tamasawa N; Takebe K
    Nihon Rinsho; 1987 Jul; 45(7):1539-46. PubMed ID: 3669350
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
    Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
    Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of chenodeoxycholic and ursodeoxycholic acids on lipid metabolism and gallstone formation in the prairie dog.
    Cohen BI; Singhal AK; Stenger RJ; May-Donath P; Finver-Sadowsky J; McSherry CK; Mosbach EH
    Hepatology; 1984; 4(2):300-7. PubMed ID: 6706304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey.
    Sarva RP; Fromm H; Farivar S; Sembrat RF; Mendelow H; Shinozuka H; Wolfson SK
    Gastroenterology; 1980 Oct; 79(4):629-36. PubMed ID: 7409382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts].
    Goszcz A
    Pol Tyg Lek; 1983 Feb; 38(7):221-4. PubMed ID: 6346288
    [No Abstract]   [Full Text] [Related]  

  • 59. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics.
    Angelin B; Nilsell K; Einarsson K
    Eur J Clin Invest; 1986 Apr; 16(2):169-77. PubMed ID: 3089812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
    Yanaura S; Izuka A; Ishikawa S
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):261-7. PubMed ID: 7327454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.